Xing‐Xing Fan
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 9
- Toxicology top 2%
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 11
- RNA modifications and cancer 6
- Cancer therapeutics and mechanisms 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 7
- Pharmacology top 5%
- Berberine and alkaloids research 6
-
- Lung Cancer Treatments and Mutations 10
- Partner nations
- MacaoChinaUnited States
In The Last Decade
Xing‐Xing Fan
98 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 622
- Toxicology 77
- Molecular Biology 1.5k
- Oncology 482
- Pharmacology 148
Countries citing papers authored by Xing‐Xing Fan
This map shows the geographic impact of Xing‐Xing Fan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing‐Xing Fan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing‐Xing Fan more than expected).
Fields of papers citing papers by Xing‐Xing Fan
This network shows the impact of papers produced by Xing‐Xing Fan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing‐Xing Fan. The network helps show where Xing‐Xing Fan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xing‐Xing Fan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 14 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 19 | |
| 6 | 2023 | 16 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 7 | |
| 11 | 2021 | 22 | |
| 12 | Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancerbreakdown → | 2021 | 177 |
| 13 | 2020 | 21 | |
| 14 | 2020 | 28 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 147 | |
| 17 | 2020 | 93 | |
| 18 | 2019 | 24 | |
| 19 | 2019 | 58 | |
| 20 | 2017 | 45 |
About Xing‐Xing Fan
Xing‐Xing Fan is a scholar working on Cancer Research, Toxicology and Complementary and alternative medicine, having authored 102 papers that have together received 2.7k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (11 papers), Cancer-related molecular mechanisms research (10 papers), Lung Cancer Treatments and Mutations (10 papers), MicroRNA in disease regulation (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Berberine and alkaloids research (6 papers), RNA modifications and cancer (6 papers) and Cancer therapeutics and mechanisms (6 papers). The work is most often cited by research in Cancer Research (622 citations), Toxicology (77 citations) and Molecular Biology (1.5k citations). Xing‐Xing Fan has collaborated with scholars based in Macao, China and United States. Frequent co-authors include Elaine Lai‐Han Leung, Liang Liu, Zebo Jiang, Qibiao Wu, Chun Xie, Xiaojun Yao, Xiaojun Yao, Ya‐Jia Xie, Liang Liu and Jumin Huang. Their work appears in journals such as Nature Communications, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.